Neogen Corp (NEOG) 45.40 $NEOG
Neogen buys Chinese distributor's assets for undisclosed fee
M2 - Tue Dec 09, 6:40AM CST
Animal safety company Neogen (NasdaqGS:NEOG) revealed on Monday the completion of the food safety and veterinary genomic assets of Beijing Anapure BioScientific Co .
NEOG: 45.40 (-0.06)
Neogen appoints Richard Calk as COO
M2 - Fri Dec 05, 4:31AM CST
Food and animal safety company Neogen (NasdaqGS:NEOG) reported on Thursday that it has appointed Richard Calk, Jr as its president and chief operating officer.
NEOG: 45.40 (-0.06)
Neogen names COO
PR Newswire - Thu Dec 04, 7:45AM CST
Neogen Corporation (NASDAQ: NEOG) announced today that it has named Richard Calk, Jr. as president and chief operating officer. He is expected to assume his responsibilities immediately. Calk replaces Steve Snyder, who resigned in July for personal reasons.
NEOG: 45.40 (-0.06)
Food Micro Report - Eighth Edition: Microbiology Testing in the Global Food Industry
M2 - Fri Nov 28, 4:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/bq4gg6/food_micro) has announced the addition of the "Food Micro - Eighth Edition: Microbiology Testing in the Global Food Industry" report to their offering. This report tracks and compares microbiology test volumes, market values and methods used by food producers around the world, based on detailed interviews with more than 450 food production facilities in North America, Europe and Asia, including China and India. According to Food Micro-8, the global food industry will conduct 966.5 million microbiology tests in 2013 to ensure the safety of food products and detect dangerous pathogens in food. The report provides detailed breakdowns by microorganisms, food segments (meat, dairy, fruit/vegetable and processed foods) and geographic regions, and summarizes key trends and concerns in microbiology testing in food production facilities around the world. This research shows a continued increase in worldwide microbiology test volumes over the last 15 years. Total test volumes have increased 128%, and testing for specific foodborne pathogens like Salmonella and E. coli grew at an even faster rate. In 1998, pathogen testing represented just 13.7% of total food microbiology tests conducted, while today pathogen testing represents 23.2% of all such tests. Food Micro-8 contains more than 100 pages of detailed graphs, analyses and discussion of key trends and issues, and includes a review of leading food diagnostic businesses and products. For the first time, additional appendices that delve into particular market topics are also available, including: Key Topics Covered: SECTION ONE: Preface SECTION TWO: Executive Summary SECTION THREE: Market Trends/Drivers SECTION FOUR: Food Microbiology Testing Market Summary SECTION FIVE: Market Projections-2018 SECTION SIX: Qualitative Discussion of Key Issues SECTION SEVEN: Geographic Region Review SECTION EIGHT: Food Segment Summary SECTION NINE: Food Diagnostics Business Review SECTION TEN: Scope and Methodology SECTION ELEVEN: Strategic Consulting, Inc. Companies Mentioned - 3M - bioMerieux - BIOTECON Diagnostics - Becton-Dickinson - Bio-Rad - BioControl - Charm Sciences - DuPont Qualicon - Foss A/S - Merck Millipore - Neogen - QIAGEN - r-Biopharm - Roka Bioscience - Romer Labs - Sigma Aldrich - Thermo/Life For more information visit http://www.researchandmarkets.com/research/bq4gg6/food_micro
ROKA: 3.95 (+0.01), MRK: 57.72 (-1.62), NEOG: 45.40 (-0.06)
ResMed Strong on Q1 Results, Huge OSA Market Potential - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 2:00PM CST
On Nov 18, 2014, we issued an updated research report on ResMed, Inc. (RMD).
BSX: 13.00 (+0.11), ABAX: 57.20 (+0.61), RMD: 53.46 (-0.13), NEOG: 45.40 (-0.06)
Comparing America's 3 Largest Diagnostic Substances Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 03, 12:03PM CST
QDEL: 25.41 (unch), NEOG: 45.40 (-0.06), IDXX: 148.86 (-0.23)
Downtrend Call Working As Neogen Stock Falls 13.1% (NEOG)
Comtex SmarTrend(R) - Mon Oct 20, 9:53AM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 12 months, Neogen has returned 13.11% as of today's recent price of $40.48.
NEOG: 45.40 (-0.06)
Shares of NEOG Down 14.7% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Oct 07, 9:32AM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 11 months, Neogen has returned 14.72% as of today's recent price of $39.73.
NEOG: 45.40 (-0.06)
Neogen acquires BioLumix for undisclosed value
M2 - Thu Oct 02, 7:03AM CDT
Food safety company Neogen (NasdaqGS:NEOG) reported on Wednesday the completion of the acquisition of all the outstanding stock of BioLumix effective 30 September 2014.
NEOG: 45.40 (-0.06)
Neogen acquires BioLumix
PR Newswire - Wed Oct 01, 12:00PM CDT
Neogen Corporation (NASDAQ: NEOG) announced today that, effective Sept. 30, it has acquired all the outstanding stock of BioLumix, Inc., an Ann Arbor, Mich.-based manufacturer and marketer of automated systems for the detection of microbial contaminants.
NEOG: 45.40 (-0.06)
Neogen Shares Down 12.6% Since SmarTrend's Sell Call (NEOG)
Comtex SmarTrend(R) - Mon Sep 29, 9:26AM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 11 months, Neogen has returned 12.64% as of today's recent price of $40.70.
NEOG: 45.40 (-0.06)
Neogen Beats Q1 Earnings by a Penny; Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 8:10AM CDT
Following the announcement of the first quarter results, Neogen Corp. (NEOG) witnessed two upward estimate revisions over the last seven days for fiscal 2015, with no downward revision over the same time frame.
ICUI: 80.95 (-1.04), CNAT: 7.94 (+0.20), NEOG: 45.40 (-0.06), EGRX: 13.25 (+0.57)
Global Rodenticides Market Outlook 2019 - Trends & Forecasts for the $900 Million Industry
M2 - Tue Sep 23, 6:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xsm6h7/rodenticides) has announced the addition of the "Rodenticides Market by Type, by End User & by Geography - Global Trends & Forecasts to 2019" report to their offering. The market for rodenticides is projected to exceed $900 million by 2019 The rodenticides market was segmented based on the basis of type and end user. Rodenticides are chemicals used for rodent control. Rodenticides are classified into anticoagulants and non-anticoagulants depending on their functionality. Rodenticides are used in agricultural fields, warehouses, pest control companies, and urban centers for effective rodent control. The rodenticides market is projected to grow with increase in demand for food grains and rise in farmer awareness regarding food spoilage due to rodents. The Asia-Pacific region was the largest rodenticides market in 2013. The rodenticides market is a fragmented market with the leading companies driving the market growth with new product launches. The report further provides qualitative analysis of the prominent market players and their preferred development strategies. Key players such as Syngenta AG (Switzerland), BASF SE (Germany), and Bayer CropScience (Germany) have been profiled in the report. The leading players have adopted new product launches as their key development strategies. Scope Of The Report On the basis of type - Anticoagulants - First generation anticoagulants - Second generation anticoagulants - Non-anticoagulants - Others (non-chemical, natural rodenticides) On the basis of end user - Agricultural field - Warehouses - Pest control companies - Urban centers - Others (household consumers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Industry Analysis 5 Market Overview 6 Market Analysis 7 Rodenticides Market, By Type 8 Rodenticides Market, By End User 9 Rodenticides Market, By Geography 10 Regulations on Rodenticides 11 Competitive Landscape 12 Company Profiles - BASF SE - Bayer Cropscience Ag - Impex Europa S.L. - J.T. Eaton & Co., Inc. - Liphatech, Inc. - Neogen Corporation - Pelgar International - Senestech, Inc. - Syngenta Sa - UPL Limited For more information visit http://www.researchandmarkets.com/research/xs...denticides
NEOG: 45.40 (-0.06)
Neogen posts 13% rise in net income & 15% in revenues
M2 - Tue Sep 23, 6:11AM CDT
Animal safety company Neogen (NasdaqGS:NEOG) stated on Monday its net income of USD8.88m for the first quarter of its 2015 fiscal year ended 31 August.
NEOG: 45.40 (-0.06)
Is Jabil Circuit (JBL) Poised to Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 6:20PM CDT
Jabil Circuit Inc. (JBL) is set to report fourth quarter fiscal 2014 results on Sep 24.
MU: 34.00 (-1.19), BBRY: 9.84 (-0.32), JBL: 19.51 (-0.59), NEOG: 45.40 (-0.06), AAPL: 109.73 (-1.89)
Can Paychex Inc. (PAYX) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 8:10AM CDT
Payroll and human resource solutions provider, Paychex Inc. (PAYX) is set to report first-quarter fiscal 2015 results on Sep 24.
MU: 34.00 (-1.19), PAYX: 46.10 (-0.77), ADP: 82.50 (-2.10), NEOG: 45.40 (-0.06)
Will Accenture Plc. (ACN) Miss Q4 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 8:00AM CDT
Accenture Plc. (ACN) is set to report fourth-quarter fiscal 2014 results on Sep 24.
MU: 34.00 (-1.19), NEOG: 45.40 (-0.06), CTSH: 50.48 (-1.03), ACN: 81.90 (-1.98)
Neogen reports 13% net income increase
PR Newswire - Mon Sep 22, 7:45AM CDT
Neogen Corporation (Nasdaq: NEOG) announced today that net income for the first quarter of its 2015 fiscal year, which ended Aug. 31, was $8,883,000 -- a 13% increase compared to net income of $7,839,000 in the first quarter of last year. Adjusted for a 3-for-2 stock split effective Oct. 30, 2013, earnings per share in the current quarter were $0.24, compared to $0.21 a year ago.
NEOG: 45.40 (-0.06)
Is a Surprise Coming for Neogen (NEOG) This Earnings Season? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 19, 7:30AM CDT
Neogen (NEOG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. The company looks set to produce a positive earnings surprise and outperform the market.
NEOG: 45.40 (-0.06)
Neogen buys Chinese distributor's assets for undisclosed fee
M2 - Tue Dec 09, 6:40AM CST
Animal safety company Neogen (NasdaqGS:NEOG) revealed on Monday the completion of the food safety and veterinary genomic assets of Beijing Anapure BioScientific Co .
NEOG: 45.40 (-0.06)
Neogen appoints Richard Calk as COO
M2 - Fri Dec 05, 4:31AM CST
Food and animal safety company Neogen (NasdaqGS:NEOG) reported on Thursday that it has appointed Richard Calk, Jr as its president and chief operating officer.
NEOG: 45.40 (-0.06)
Neogen names COO
PR Newswire - Thu Dec 04, 7:45AM CST
Neogen Corporation (NASDAQ: NEOG) announced today that it has named Richard Calk, Jr. as president and chief operating officer. He is expected to assume his responsibilities immediately. Calk replaces Steve Snyder, who resigned in July for personal reasons.
NEOG: 45.40 (-0.06)
Food Micro Report - Eighth Edition: Microbiology Testing in the Global Food Industry
M2 - Fri Nov 28, 4:51AM CST
Research and Markets (http://www.researchandmarkets.com/research/bq4gg6/food_micro) has announced the addition of the "Food Micro - Eighth Edition: Microbiology Testing in the Global Food Industry" report to their offering. This report tracks and compares microbiology test volumes, market values and methods used by food producers around the world, based on detailed interviews with more than 450 food production facilities in North America, Europe and Asia, including China and India. According to Food Micro-8, the global food industry will conduct 966.5 million microbiology tests in 2013 to ensure the safety of food products and detect dangerous pathogens in food. The report provides detailed breakdowns by microorganisms, food segments (meat, dairy, fruit/vegetable and processed foods) and geographic regions, and summarizes key trends and concerns in microbiology testing in food production facilities around the world. This research shows a continued increase in worldwide microbiology test volumes over the last 15 years. Total test volumes have increased 128%, and testing for specific foodborne pathogens like Salmonella and E. coli grew at an even faster rate. In 1998, pathogen testing represented just 13.7% of total food microbiology tests conducted, while today pathogen testing represents 23.2% of all such tests. Food Micro-8 contains more than 100 pages of detailed graphs, analyses and discussion of key trends and issues, and includes a review of leading food diagnostic businesses and products. For the first time, additional appendices that delve into particular market topics are also available, including: Key Topics Covered: SECTION ONE: Preface SECTION TWO: Executive Summary SECTION THREE: Market Trends/Drivers SECTION FOUR: Food Microbiology Testing Market Summary SECTION FIVE: Market Projections-2018 SECTION SIX: Qualitative Discussion of Key Issues SECTION SEVEN: Geographic Region Review SECTION EIGHT: Food Segment Summary SECTION NINE: Food Diagnostics Business Review SECTION TEN: Scope and Methodology SECTION ELEVEN: Strategic Consulting, Inc. Companies Mentioned - 3M - bioMerieux - BIOTECON Diagnostics - Becton-Dickinson - Bio-Rad - BioControl - Charm Sciences - DuPont Qualicon - Foss A/S - Merck Millipore - Neogen - QIAGEN - r-Biopharm - Roka Bioscience - Romer Labs - Sigma Aldrich - Thermo/Life For more information visit http://www.researchandmarkets.com/research/bq4gg6/food_micro
ROKA: 3.95 (+0.01), MRK: 57.72 (-1.62), NEOG: 45.40 (-0.06)
ResMed Strong on Q1 Results, Huge OSA Market Potential - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Nov 19, 2:00PM CST
On Nov 18, 2014, we issued an updated research report on ResMed, Inc. (RMD).
BSX: 13.00 (+0.11), ABAX: 57.20 (+0.61), RMD: 53.46 (-0.13), NEOG: 45.40 (-0.06)
Comparing America's 3 Largest Diagnostic Substances Companies
Joseph Cafariello - at Seeking Alpha - Mon Nov 03, 12:03PM CST
QDEL: 25.41 (unch), NEOG: 45.40 (-0.06), IDXX: 148.86 (-0.23)
Downtrend Call Working As Neogen Stock Falls 13.1% (NEOG)
Comtex SmarTrend(R) - Mon Oct 20, 9:53AM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 12 months, Neogen has returned 13.11% as of today's recent price of $40.48.
NEOG: 45.40 (-0.06)
Shares of NEOG Down 14.7% Since Downtrend Call on Shares
Comtex SmarTrend(R) - Tue Oct 07, 9:32AM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 11 months, Neogen has returned 14.72% as of today's recent price of $39.73.
NEOG: 45.40 (-0.06)
Neogen acquires BioLumix for undisclosed value
M2 - Thu Oct 02, 7:03AM CDT
Food safety company Neogen (NasdaqGS:NEOG) reported on Wednesday the completion of the acquisition of all the outstanding stock of BioLumix effective 30 September 2014.
NEOG: 45.40 (-0.06)
Neogen acquires BioLumix
PR Newswire - Wed Oct 01, 12:00PM CDT
Neogen Corporation (NASDAQ: NEOG) announced today that, effective Sept. 30, it has acquired all the outstanding stock of BioLumix, Inc., an Ann Arbor, Mich.-based manufacturer and marketer of automated systems for the detection of microbial contaminants.
NEOG: 45.40 (-0.06)
Neogen Shares Down 12.6% Since SmarTrend's Sell Call (NEOG)
Comtex SmarTrend(R) - Mon Sep 29, 9:26AM CDT
SmarTrend identified a Downtrend for Neogen (NASDAQ:NEOG) on October 31st, 2013 at $46.59. In approximately 11 months, Neogen has returned 12.64% as of today's recent price of $40.70.
NEOG: 45.40 (-0.06)
Neogen Beats Q1 Earnings by a Penny; Revenues Miss - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Sep 26, 8:10AM CDT
Following the announcement of the first quarter results, Neogen Corp. (NEOG) witnessed two upward estimate revisions over the last seven days for fiscal 2015, with no downward revision over the same time frame.
ICUI: 80.95 (-1.04), CNAT: 7.94 (+0.20), NEOG: 45.40 (-0.06), EGRX: 13.25 (+0.57)
Global Rodenticides Market Outlook 2019 - Trends & Forecasts for the $900 Million Industry
M2 - Tue Sep 23, 6:23AM CDT
Research and Markets (http://www.researchandmarkets.com/research/xsm6h7/rodenticides) has announced the addition of the "Rodenticides Market by Type, by End User & by Geography - Global Trends & Forecasts to 2019" report to their offering. The market for rodenticides is projected to exceed $900 million by 2019 The rodenticides market was segmented based on the basis of type and end user. Rodenticides are chemicals used for rodent control. Rodenticides are classified into anticoagulants and non-anticoagulants depending on their functionality. Rodenticides are used in agricultural fields, warehouses, pest control companies, and urban centers for effective rodent control. The rodenticides market is projected to grow with increase in demand for food grains and rise in farmer awareness regarding food spoilage due to rodents. The Asia-Pacific region was the largest rodenticides market in 2013. The rodenticides market is a fragmented market with the leading companies driving the market growth with new product launches. The report further provides qualitative analysis of the prominent market players and their preferred development strategies. Key players such as Syngenta AG (Switzerland), BASF SE (Germany), and Bayer CropScience (Germany) have been profiled in the report. The leading players have adopted new product launches as their key development strategies. Scope Of The Report On the basis of type - Anticoagulants - First generation anticoagulants - Second generation anticoagulants - Non-anticoagulants - Others (non-chemical, natural rodenticides) On the basis of end user - Agricultural field - Warehouses - Pest control companies - Urban centers - Others (household consumers) Key Topics Covered: 1 Introduction 2 Executive Summary 3 Premium Insights 4 Industry Analysis 5 Market Overview 6 Market Analysis 7 Rodenticides Market, By Type 8 Rodenticides Market, By End User 9 Rodenticides Market, By Geography 10 Regulations on Rodenticides 11 Competitive Landscape 12 Company Profiles - BASF SE - Bayer Cropscience Ag - Impex Europa S.L. - J.T. Eaton & Co., Inc. - Liphatech, Inc. - Neogen Corporation - Pelgar International - Senestech, Inc. - Syngenta Sa - UPL Limited For more information visit http://www.researchandmarkets.com/research/xs...denticides
NEOG: 45.40 (-0.06)
Neogen posts 13% rise in net income & 15% in revenues
M2 - Tue Sep 23, 6:11AM CDT
Animal safety company Neogen (NasdaqGS:NEOG) stated on Monday its net income of USD8.88m for the first quarter of its 2015 fiscal year ended 31 August.
NEOG: 45.40 (-0.06)
Is Jabil Circuit (JBL) Poised to Beat Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 6:20PM CDT
Jabil Circuit Inc. (JBL) is set to report fourth quarter fiscal 2014 results on Sep 24.
MU: 34.00 (-1.19), BBRY: 9.84 (-0.32), JBL: 19.51 (-0.59), NEOG: 45.40 (-0.06), AAPL: 109.73 (-1.89)
Can Paychex Inc. (PAYX) Surprise this Earnings Season? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 8:10AM CDT
Payroll and human resource solutions provider, Paychex Inc. (PAYX) is set to report first-quarter fiscal 2015 results on Sep 24.
MU: 34.00 (-1.19), PAYX: 46.10 (-0.77), ADP: 82.50 (-2.10), NEOG: 45.40 (-0.06)
Will Accenture Plc. (ACN) Miss Q4 Earnings Estimates? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Sep 22, 8:00AM CDT
Accenture Plc. (ACN) is set to report fourth-quarter fiscal 2014 results on Sep 24.
MU: 34.00 (-1.19), NEOG: 45.40 (-0.06), CTSH: 50.48 (-1.03), ACN: 81.90 (-1.98)
Neogen reports 13% net income increase
PR Newswire - Mon Sep 22, 7:45AM CDT
Neogen Corporation (Nasdaq: NEOG) announced today that net income for the first quarter of its 2015 fiscal year, which ended Aug. 31, was $8,883,000 -- a 13% increase compared to net income of $7,839,000 in the first quarter of last year. Adjusted for a 3-for-2 stock split effective Oct. 30, 2013, earnings per share in the current quarter were $0.24, compared to $0.21 a year ago.
NEOG: 45.40 (-0.06)
Is a Surprise Coming for Neogen (NEOG) This Earnings Season? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Sep 19, 7:30AM CDT
Neogen (NEOG) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. The company looks set to produce a positive earnings surprise and outperform the market.
NEOG: 45.40 (-0.06)
